![]() |
Corporate Governance for Public Company Direct |
|
Media:Price Per Unit:
$97.00 |
ISBN:9780735541030 Format:Paperback More Info: 888-224-7377 |
|
Corporate Governance for Public Company Directors takes you step-by-step through the new regulatory requirements that now shape the role of the corporate director. You'll find all of the information you need, including complete coverage of:
In this essential new work, the author:
Finally, and of great value, the author tells directors how to work together cohesively, what "red flags" to look for that signal trouble on the horizon and what factors to consider in deciding whether to accept a directorship... or resign from one!
Many of the book's best chapters are short and pithy. A few chapters, such as those on the specialized roles of the compensation and audit committees under the new standards, require (but reward) patience with the detail. These have become complex technical subjects that are almost meaningless without the details.
The number of practical suggestions in this little book is amazing, and although not every corporate governance expert will agree with every suggestion, taken as a whole, the compendium is uniquely useful. Having himself been a senior corporate officer and director, and a partner in two national law firms, as well as independent counsel to mutual fund and other boards, the author knows, as much as anyone today, whereof he writes.
Turn to Corporate Governance for Public Company Directors for quick, expert advice on what directors need to know about the new rules, and how to be a hero in today's corporate climate.
SEC Deputy Director Shelley Parratt urged companies not to wait for staff comments to improve their compensation discussion and analysis ("CD&A"). After three years of comments on how to improve their disclosure, Parratt said companies now should be prepared to amend their filings if they do not materially comply with the rules.
Insights into legislative activity, cases of note, and other breaking news.
Insights and commentary on health reform.
A forum to discuss antitrust and trade regulation law.
Commentary and musings about securities regulation.